MYSTERIOUS: 21 - You Need To See This

A Quarterly Injection Cut Acute Pancreatitis Attacks by 78 Percent in Adults with Dangerously High Triglycerides

Two Phase 3 trials of plozasiran cut triglycerides by about 80% and reduced acute pancreatitis events by 78%. An FDA filing is expected by year-end.

Medical Daily · Sep 2

The FDA Has Put Its Strongest Warning on a Common Iron Infusion Over Dangerously Low Phosphate

FDA added a boxed warning to Injectafer over symptomatic hypophosphatemia. Fewer than 20% of infusions include a blood test that would catch it.

Medical Daily · Sep 2

A Seed Supplier Linked to a Fifteen State Sprout Outbreak Has Not Answered the FDA's Recall Request

FDA says the alfalfa seed supplier in a 15-state sprout outbreak has not answered its recall request and another grower used the same lot.

Medical Daily · Sep 2

Adding a Second Pill to Tagrisso Delayed Lung Cancer Progression in Newly Diagnosed Patients in China

A phase 3 trial in China found savolitinib plus osimertinib delayed progression in first-line MET-overexpressing EGFR-mutated lung cancer.

Medical Daily · Sep 2

Millions Take Zyrtec Daily, and Stopping After Months of Use Can Trigger Severe Itching in Rare Cases

Federal regulators require a warning about severe itching after stopping long-term cetirizine or levocetirizine. What allergy patients should know.

Medical Daily · Sep 2

Breast Ultrasound Kits Join a 16 Record Medline Recall Traced to Wrinkled Packaging on Sterile Skin Applicators

FDA classified a Medline recall covering ultrasound breast packs plus 15 other kit records over a possible sterile barrier breach.

Medical Daily · Sep 2

Cesarean and Delivery Prep Trays Are Among 13 Medline Kit Recalls Tied to Faulty Applicator Seals

FDA classified 13 Medline convenience kit recall records covering 222,653 units, including cesarean and labor and delivery prep trays.

Medical Daily · Sep 2

An Oral Pill for Relapsing MS Beat a Standard Drug in Two Trials with No Figures Released

Novartis says remibrutinib beat teriflunomide in two Phase 3 MS trials. The company released no numbers and the data are unpublished.

Medical Daily · Sep 2

One Lot of a Medication Used to Prevent Alcohol Relapse Failed a Dissolution Test in Nationwide Recall

A single lot of acamprosate was recalled after failing dissolution testing. Patients should check with a pharmacy without interrupting treatment.

Medical Daily · Sep 2

Black Spots on Seizure Pills Trigger a Nationwide Recall and the Wrong Reaction Could Be Dangerous

A nationwide recall covers 1,968 bottles of carbamazepine tablets with black spots. Stopping a seizure drug abruptly carries its own risks.

Medical Daily · Sep 2